Thermo Fisher ScientificvsVoyager Therapeutics

TMO and VYGR stock compared: price, dividend, valuation and results, from SEC filings.

TMO

Thermo Fisher Scientific Inc

$700.22

Value $260B

+0.11%
TMO's page

VYGR

Voyager Therapeutics, Inc.

$1.73

Value $103M

+1.76%
VYGR's page

Thermo Fisher Scientific (TMO) has a market value of $260B and Voyager Therapeutics (VYGR) $103M. Over the last year, with dividends, TMO moved +19.5% and VYGR -59.3%. Dividend yield: TMO 0.26%, VYGR none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    TMO$260B

    VYGR$103M

    TMO is 2,523 times VYGR

  • Revenue, 12 months

    TMO$47.4B

    VYGR$25M

    TMO is 1,886 times VYGR

  • Net income, 12 months

    TMO$7.1B

    VYGR-$105M

  • Operating margin

    TMO17.9%

    VYGR-450.1%

    468.0 points apart

  • ROIC

    TMO8.2%

    VYGR-50.8%

    59.0 points apart

  • P/E

    TMO36.8

    VYGR–

  • Dividend yield

    TMO0.3%

    VYGR0.0%

    0.3 points apart

  • 5-year return

    TMO+11.8%

    VYGR-48.8%

    60.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

TMO+11.8%

VYGR-48.8%

10020030040020222023202420252026
Returns by period
PeriodTMOWith dividendsVYGRWith dividends
1 year since November 12, 2025+19.5%Price +19.1%-59.3%Price -59.3%
3 years since November 13, 2023+58.8%+16.7% a yearPrice +57.3%-72.5%-34.9% a yearPrice -72.5%
5 years since November 12, 2021+11.8%+2.3% a yearPrice +10.2%-48.8%-12.5% a yearPrice -48.8%
10 years since November 15, 2016+384.5%+17.1% a yearPrice +371.0%-87.6%-18.8% a yearPrice -87.6%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

TMOThermo Fisher ScientificVYGRVoyager Therapeutics

Valuation

TMOVYGR
Valuation
Price$700.22$1.73
Market value$260B$103M
Enterprise value (EV)$295B–
P/E36.8–
P/E, 5-year median32.7–
P/B4.80.8
EV/EBIT34.9–
Free cash flow yield2.9%–

Results and growth

TMOVYGR
Results and growth
Revenue, 12 months$47.4B$25M
Net income, 12 months$7.1B-$105M
Free cash flow, 12 months$7.6B-$110M
Earnings per share, 12 months$18.96-$1.74
Revenue growth, year on year3.9%-49.5%
Revenue growth a year, past+6.7%over 5 years-25.1%over 5 years
EPS growth a year, past+2.1%over 5 years–

Margins and returns on capital

TMOVYGR
Margins and returns on capital
Gross margin––
Operating margin17.9%-450.1%
Net margin14.9%-416.3%
ROIC8.2%-50.8%
ROE13.4%-59.5%

Balance sheet

TMOVYGR
Balance sheet
Cash$6.1B$132M
Total debt$41.4B$31M
Net debt / EBITDA3.7–
Interest cover5.5×–

Dividends and buybacks

TMOVYGR
Dividends and buybacks
Dividend yield0.3%–
Dividend per share, 12 months$1.84–
Dividend growth a year, past+14.3%over 5 years–
Buyback yield1.2%–
Shareholder yield1.4%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: TMO or VYGR

Didn't find what you were looking for?

Ask us
Which is bigger, Thermo Fisher Scientific or Voyager Therapeutics?

By market value, Thermo Fisher Scientific ($260B) is about 2,522.8 times Voyager Therapeutics ($103M), at today's prices.

How did TMO and VYGR stock do over the last 10 years?

Since November 15, 2016, TMO's price moved +371.0% and VYGR's -87.6%. With dividends: TMO +384.5% (+17.1% a year), VYGR -87.6% (-18.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, TMO or VYGR?

The dividend yield at today's price is 0.26% for Thermo Fisher Scientific and none for Voyager Therapeutics. Over the last twelve months they paid $1.84 and – per share.

Which has the higher profit margins, Thermo Fisher Scientific or Voyager Therapeutics?

Over the last twelve months, the net margin was 14.9% for Thermo Fisher Scientific and -416.3% for Voyager Therapeutics, and the operating margin 17.9% and -450.1%. Revenue was $47.4B and $25M.

Which is the better investment, Thermo Fisher Scientific or Voyager Therapeutics?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.